Fate Therapeutics (FATE) News
NASDAQ: FATEHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
2.18+0.05 (+2.35%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
FATE news summary
We found 1 recent headline mentioning Fate Therapeutics (FATE): 0 in the past week and 0 in the past 30 days, most often from Nasdaq. For price context, FATE is up 2.35% at $2.18. The most recent story, "Johnson & Johnson Owns Stakes in 15 Stocks. Here's the Best of the Bunch.", was published by Nasdaq on Aug 31, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology